logo
logo
Community
Pricing
Sign in
menu-h

The U.S. Acellular Dermal Matrices Market Growth Accelerated by Rising Use in Breast Reconstruction Surgeries

avatar
Mia Yates
The U.S. Acellular Dermal Matrices Market Growth Accelerated by Rising Use in Breast Reconstruction Surgeries

Acellular dermal matrices are a sterilized human or animal-derived dermal collagen tissue used as an implant under soft tissues, such as the breast or abdomen, during reconstructive procedures. These matrices act as a scaffold that promotes tissue integration and vascularization at the recipient site. Their use helps support soft tissues and creates smoother contours. With rising breast cancer cases and prevalence of mastectomies, the demand for acellular dermal matrices has increased substantially for breast reconstruction surgeries.

The U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the key trends driving the growth of the U.S. acellular dermal matrices market is the increasing adoption of alloderm and strattice by plastic surgeons. Alloderm and strattice are the most commonly used acellular dermal matrices brands in breast reconstruction surgeries. Their established efficacy and safety profiles have resulted in growing preference over other available alternatives. According to the American Society of Plastic Surgeons, the use of acellular dermal matrices in breast reconstruction procedures doubled from 2013 to 2018. Additionally, ongoing product innovations such as the launch of thinner and softer generation matrices are also aiding the market expansion.


Segment Analysis

The U.S. acellular dermal matrices market is dominated by the skin/soft tissue repair and reconstruction segment. This is due to the wide usage of acellular dermal matrices for reconstructive procedures such as breast reconstruction. The breast reconstruction sub-segment accounts for over 35% of market share as acellular dermal matrices help minimize deformities and loss of breast shape post-surgery.

Key Takeaways

The U.S. Acellular Dermal Matrices Market Size is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030.

Regional analysis

The South and West regions of the United States hold over 60% of market share collectively due to higher patient awareness, accessible healthcare facilities and presence of leading market players. California is expected to witness highest CAGR of 7.2% during the forecast period driven by growing geriatric population and increasing cases of breast cancer.

Key players

Key players operating in the U.S. acellular dermal matrices market are LifeCell Corporation, Mylan, BD, Allergan and Organogenesis. LifeCell holds over 25% of market share owing to its flagship product AlloDerm, widely used for breast reconstruction procedures. Mylan has been increasingly gaining market share since 2021 by expanding its portfolio of acellular dermal matrices including Xcellerant.

For More Insights, Read: https://www.newswirestats.com/u-s-acellular-dermal-matrices-market-size-share-and-growth-forecast-2023-2030/

collect
0
avatar
Mia Yates
Related Articles
Growth Accelerated By Increasing Adoption In Soft Tissue Reconstruction Applications.
Leena Shedmake 2024-01-04
img
With the increasing prevalence of breast cancer and soft tissue injuries, the demand for acellular dermal matrices is rising. With the rising incidence of breast cancer worldwide, there is an increasing need for breast reconstruction procedures which utilize acellular dermal matrices to replace damaged or deficient soft tissue. As such, the growing number of breast reconstruction procedures will augment the demand for acellular dermal matrices over the forecast period. This is because allograft matrices are more natural and better resemble human soft tissues as compared to other synthetic dermal matrices. States like Florida and Texas have highest number of cosmetic procedures driving the demand for dermal matrices in this region.
collect
0
Tissue Regeneration Contributing Large Share In The Acellular Dermal Matrices Market
Sachin Sadgir 2023-11-03
img
The global Acellular Dermal Matrices Market is estimated to be valued at US$ 8. The growing prevalence of burns, injuries and soft tissue defects is driving the need for acellular dermal matrices. Segment Analysis The global acellular dermal matrices market is dominated by the alloderm segment, accounting for over 35% of the total market share. Alloderm is a type of acellular dermal matrices made from human tissue that acts as a scaffold for tissue regeneration. Regional analysis The US dominates the global acellular dermal matrices market currently, accounting for over 40% of the total market share.
collect
0
Global U.S. Acellular Dermal Matrices Market Growth Accelerated by Rising Skin Grafting Procedures
Sneha 2023-12-29
img
The growing prevalence of burns and skin ulcers along with rising plastic and reconstructive surgeries are driving the demand for acellular dermal matrices. Similarly, in 2019, Stratatech Corporation launched a family of HydroToneTM Acellular Dermal Matrix products for wound repair and reconstruction. The tissue is processed to remove cellular components while maintaining the structural proteins to mimic natural dermal tissue. offers various tissue processing services and acellular dermal matrices under its brands such as AlloDerm and DermaMatrix. provides acellular dermal matrices under the GraftJacket brand.
collect
0
Acellular Dermal Matrices: A Safe and Effective Treatment for Burns
Pooja salve 2023-07-12
img
This leaves behind a scaffold that is rich in collagen, elastin, and other proteins that are essential for wound healing. They are also more durable than traditional skin grafts, which makes them a better option for large or deep burns. In a study of 100 patients with burns, ADMs were found to be as effective as skin grafts in terms of wound healing time and cosmetic outcome. They are more biocompatible than synthetic dressings and more durable than traditional skin grafts. They are also a good option for people who do not have enough healthy skin to donate for a skin graft.
collect
0
The U.S. Opioids Market Growth Accelerated by Increasing Demand for Pain Management
Mia Yates 2024-01-29
img
The increasing prevalence of chronic diseases and disorders has accelerated the demand for effective pain management drugs. Prescription opioids are the mainstay for management of moderate to severe acute and chronic pain. 39 Mn in 2024 and is expected to exhibit a CAGR of 4. Easy availability of these medications over the counter and prescription opioid pain relievers for chronic and acute pain treatment has led to widespread use. 39 Mn in 2024 and is expected to exhibit a CAGR of 4. S opioids market owing to higher incidence of chronic pain disorders and availability of prescription opioid medications.
collect
0
Acellular Therapy Market Size, Share, Growth, Opportunities and Global Forecast to 2030
Vishakha Gome 2023-06-14
img
The new Acellular Therapy Market report offers a comprehensive study of the current scenario of the market including major market dynamics. Get more information on "Global Acellular Therapy Market Research Report" by requesting FREE Sample Copy at https://www. This supportive regulatory environment is expected to support market growth by reducing barriers to market entry for new acellular therapy products. Browse Global Acellular Therapy Market Research Report with detailed TOC at https://www. Purchase Complete Global Acellular Therapy Market Research Report at https://www.
collect
0
WHO TO FOLLOW
MORE FROM AUTHOR
Beyond Classical Limits: Quantum Key Distribution as the Pinnacle of Secure Communication
Mia Yates 2024-02-26
img
collect
0
Pyrethroids in Agriculture: Balancing Efficacy, Safety, and Environmental Sustainability
Mia Yates 2024-02-26
img
collect
0
The Smallpox Treatment Market Will Grow At Highest Pace Owing To Rising Investment In Vaccine Development And Production
Mia Yates 2024-02-26
img
collect
0
Robot Suitcase Market Will Grow At Highest Pace Owing To Increasing Demand For Medical Mobility Among Aged Population
Mia Yates 2024-02-26
img
collect
0
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more
WHO TO FOLLOW
Press enter to search  enter
articles
Acellular Therapy Market - Strategies and Applications
bisresearch reports 2022-04-20
img
The benefits of stem cell therapy through paracrine actions have led to the development of a cell-free therapeutic method, also known as acellular therapy. Cell-Free Therapy• Application of Extracellular Vesicles (EVs) in Regenerative Medicine• Acellular Therapy: A Novel Approach for COVID-19• Expert Insights• Clinical Trial Analysis: Acellular Therapy• Extracellular Vesicles-Based Therapeutics: Regulatory Aspects• Competitive LandscapeKey Questions Answered in this Report:• What is acellular therapy? • Who are the leading players with significant offerings to the acellular therapy market, and what is the current market dominance for each of these leading players? • Which regulatory procedures are required to unify the approval process for the emerging acellular therapy market? • What are the gaps in regularizing acellular therapy market adoption in regular healthcare routines, and how are these gaps being tackled?
collect
0
Advancing Tissue Engineering Propels Growth Of The U.S. Acellular Dermal Matrices Market
Akanksha Gaikwad 2024-03-12
img
The development of new generation acellular dermal matrices with advanced properties is gaining traction. S acellular dermal matrices market is the rising preference for regenerative therapies over alternative treatments. The capability of acellular dermal matrices to catalyze natural tissue regeneration without unwanted host responses makes them attractive options for treating soft tissue injuries and defects. The high costs associated with R&D and production of acellular dermal matrices remain a key limiting factor, especially in price-sensitive developing regions. Porcine animals are commonly used source for xenogeneic acellular dermal matrices.
collect
0
Dermal Filler Global Market Report 2022 By Type, Share, Drivers, Segmentation And Forecast 2031
Pooja tbrc 2022-09-29
img
The Dermal Filler Global Market Report 2021-31 by The Business Research Company describes and explains the global dermal filler market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The global dermal filler market size is expected to grow to $7. id=6442&type=smp   Dermal Filler Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. Africa Dermal Filler Market 27. Appendix  About The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.
collect
0
U.S. Naloxone Market Estimated to Witness High Growth Owing to Increasing Opioid Overdose Cases
Omkar Patel 2024-01-12
img
It is approved by the Food and Drug Administration (FDA) for emergency medical treatment of known or suspected opioid overdose. While opioid overdose driven demand is a major factor, growing awareness via NGO campaigns about opioid addiction and availability of overdose reversal drugs is anticipated to further bolster the U. Public health campaigns aim to reduce the stigma around opioid use disorders and naloxone, encouraging more people to keep it available. Threats: Growing availability and social acceptance of naloxone may weaken deterrence for risky opioid behaviors in some users. Regional analysis indicates the highest number of overdose deaths occurred in Northeastern states, making it currently the dominant market for naloxone products.
collect
0
U.S. Opioids Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Chronic Pain
Ashish Thapa 2023-09-12
img
The advantages of opioids include their ability to alleviate pain and improve the quality of life for patients with chronic pain conditions. The need for these products is driven by the increasing prevalence of chronic pain across the United States. The market is driven by increasing cases of chronic pain, the aging population, and the growing prevalence of conditions requiring palliative care. Furthermore, the rising awareness about pain management and the introduction of advanced technologies are also contributing to market growth. Regionally, the United States dominates the opioids market due to its well-established healthcare infrastructure, high healthcare expenditure, and the prevalence of chronic pain conditions.
collect
0
U.S. Home Healthcare Market Growing Demand for in-Home Healthcare Services
Rajkumar cmi 2024-01-11
img
These services range from skilled nursing care and intravenous therapy to physiotherapy and assistance with daily living activities. The growing geriatric population prone to chronic diseases and disabilities has increased demand for such in-home services. Its widespread acceptance is set to drive further growth in the home healthcare market. Among these, the services segment dominates the market as people are increasingly preferring home health care for convenience and cost-effectiveness. Specifically, skilled nursing services is the largest sub-segment since it provides specialized care to patients through licensed nurses and therapists.
collect
0
U.S. Naloxone Market is Estimated to Witness High Growth Owing to Increasing Cases of Opioid Overdose
Gauri Cmi 2023-09-18
img
The market is driven by the increasing cases of opioid overdose, which has become a major public health concern in the United States. Recognizing the urgency and severity of the opioid overdose crisis, many states in the U. These programs provide training to individuals on how to recognize the signs of opioid overdose and administer naloxone effectively. The government's initiatives to combat the opioid crisis and increase access to naloxone are expected to drive market growth. Additionally, the societal acceptance and promotion of naloxone as a critical intervention in opioid overdose emergencies contribute to market growth.
collect
0
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight
Ankit Nigam 2020-10-12
img

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.

These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.

According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.

The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.

Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.

collect
0
U.S. Sucralfate Market to Grow with Rising Demand for Peptic Ulcer Treatment
Purvaja 2024-02-21
img
The U. The U. The sucralfate market witnesses high demand in the U. Social: As life expectancy increases, the aging population is more susceptible to gastrointestinal diseases requiring sucralfate treatment. The U. Factors such as high healthcare expenditure, growing pharmaceutical industry, and presence of key market players have supported market concentration in the U. The Asia Pacific region is projected to be the fastest growing market during the forecast period.
collect
0
The global U.S. Nasal Spray Market Growth Accelerated by Increasing Prevalence of Allergies
Sumedha 2024-01-04
img
Demand for nasal sprays is increasing owing to rising prevalence of allergic rhinitis and sinusitis conditions among people. 5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. As per American Academy of Allergy Asthma & Immunology (AAAAI), more than 60 million Americans experience allergic rhinitis yearly. This growing patient pool experiencing nasal blockage and other allergy symptoms will continue driving demand for effective nasal spray medications over the forecast period. Companies operating in this market have an opportunity to launch new products targeting specific allergy types and expand existing line of nasal sprays to cash-in on increased need for relief from nasal congestion and sinusitis.
collect
0
The surging demand for treatment of speech and language disorders opens lucrative opportunities in the U.S. speech therapy market
samruddhicmi123 2023-10-27
img
The Speech therapy Market is estimated to be valued at US$ 4. The increasing awareness about available treatment options and their effectiveness is prompting more people to opt for speech therapy. This is due to the rising prevalence of speech disorders among children such as stuttering, articulation disorders, and language delay. Pediatric speech therapy helps children in developing communication and speech skills which is important for childhood development. , Easy Speech Therapy Center, LA Speech Therapy Solutions, LLC, Teamwork Therapies, and The Hello Foundation.
collect
0
What are the Current Trends and Key Players in the Dermal Filler Market?
Kanika Gupte 2022-09-19
img
com/request-sample/7654Dermal Filler Market business research report assesses the current as well as upcoming performance of the market, and also brand-new trends in the market. It provides product overview and highlights of product and application segments of the Dermal Filler Market including price, revenue, sales, sales growth rate, and market share by product. The Dermal Filler Market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics. Considering these factors, COVID-19 is expected to have a significant impact on the dermal filler market. The dermal filler market is not limited to facial skin procedures, but also includes treatment, which aesthetically changes the body.
collect
0
Evolving Perspectives: Ethanol's Role in the U.S. Fuel Sector
Vedant B 2024-03-26
img
S ethanol market has witnessed significant growth over the past few years due to the increasing demand for sustainable transportation fuels. The Renewable Fuel Standard program mandates blending of minimum volumes of renewable fuels like ethanol in gasoline every year. Infrastructure constraints also exist for sales and distribution of higher ethanol blends like E15 that require modifications at dispensing pumps. Over 50% of total ethanol production capacity is based in these states due to strategic location in the corn belt. Stringent low carbon fuel policies and presence of major fuel markets favor ethanol consumption growth in this region.
collect
0
The global U.S. Imaging Services Market Growth Accelerated by Digital Adoption
Niranjan Mardakar 2024-02-01
img
The U. The U. 3 Mn in 2024 and is expected to exhibit a CAGR of 4. 9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. This has increased accessibility of quality medical imaging services to large population base. This segment is dominating as diagnostic imaging enables early detection of diseases as well as aid in treatment decisions planning and monitoring. The U. 3 Mn in 2024 and is expected to exhibit a CAGR of 4.
collect
0
Acellular Therapy Market - Strategies and Applications
bisresearch reports 2022-04-20
img
The benefits of stem cell therapy through paracrine actions have led to the development of a cell-free therapeutic method, also known as acellular therapy. Cell-Free Therapy• Application of Extracellular Vesicles (EVs) in Regenerative Medicine• Acellular Therapy: A Novel Approach for COVID-19• Expert Insights• Clinical Trial Analysis: Acellular Therapy• Extracellular Vesicles-Based Therapeutics: Regulatory Aspects• Competitive LandscapeKey Questions Answered in this Report:• What is acellular therapy? • Who are the leading players with significant offerings to the acellular therapy market, and what is the current market dominance for each of these leading players? • Which regulatory procedures are required to unify the approval process for the emerging acellular therapy market? • What are the gaps in regularizing acellular therapy market adoption in regular healthcare routines, and how are these gaps being tackled?
U.S. Sucralfate Market to Grow with Rising Demand for Peptic Ulcer Treatment
Purvaja 2024-02-21
img
The U. The U. The sucralfate market witnesses high demand in the U. Social: As life expectancy increases, the aging population is more susceptible to gastrointestinal diseases requiring sucralfate treatment. The U. Factors such as high healthcare expenditure, growing pharmaceutical industry, and presence of key market players have supported market concentration in the U. The Asia Pacific region is projected to be the fastest growing market during the forecast period.
Advancing Tissue Engineering Propels Growth Of The U.S. Acellular Dermal Matrices Market
Akanksha Gaikwad 2024-03-12
img
The development of new generation acellular dermal matrices with advanced properties is gaining traction. S acellular dermal matrices market is the rising preference for regenerative therapies over alternative treatments. The capability of acellular dermal matrices to catalyze natural tissue regeneration without unwanted host responses makes them attractive options for treating soft tissue injuries and defects. The high costs associated with R&D and production of acellular dermal matrices remain a key limiting factor, especially in price-sensitive developing regions. Porcine animals are commonly used source for xenogeneic acellular dermal matrices.
The global U.S. Nasal Spray Market Growth Accelerated by Increasing Prevalence of Allergies
Sumedha 2024-01-04
img
Demand for nasal sprays is increasing owing to rising prevalence of allergic rhinitis and sinusitis conditions among people. 5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. As per American Academy of Allergy Asthma & Immunology (AAAAI), more than 60 million Americans experience allergic rhinitis yearly. This growing patient pool experiencing nasal blockage and other allergy symptoms will continue driving demand for effective nasal spray medications over the forecast period. Companies operating in this market have an opportunity to launch new products targeting specific allergy types and expand existing line of nasal sprays to cash-in on increased need for relief from nasal congestion and sinusitis.
Dermal Filler Global Market Report 2022 By Type, Share, Drivers, Segmentation And Forecast 2031
Pooja tbrc 2022-09-29
img
The Dermal Filler Global Market Report 2021-31 by The Business Research Company describes and explains the global dermal filler market and covers 2016 to 2021, termed the historic period, and 2022 to 2026, termed the forecast period, along with further forecasts for the period 2026-2031. The global dermal filler market size is expected to grow to $7. id=6442&type=smp   Dermal Filler Global Market Report 2022 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. Africa Dermal Filler Market 27. Appendix  About The Business Research Company:  The Business Research Company is a market intelligence firm that excels in company, market, and consumer research.
The surging demand for treatment of speech and language disorders opens lucrative opportunities in the U.S. speech therapy market
samruddhicmi123 2023-10-27
img
The Speech therapy Market is estimated to be valued at US$ 4. The increasing awareness about available treatment options and their effectiveness is prompting more people to opt for speech therapy. This is due to the rising prevalence of speech disorders among children such as stuttering, articulation disorders, and language delay. Pediatric speech therapy helps children in developing communication and speech skills which is important for childhood development. , Easy Speech Therapy Center, LA Speech Therapy Solutions, LLC, Teamwork Therapies, and The Hello Foundation.
U.S. Naloxone Market Estimated to Witness High Growth Owing to Increasing Opioid Overdose Cases
Omkar Patel 2024-01-12
img
It is approved by the Food and Drug Administration (FDA) for emergency medical treatment of known or suspected opioid overdose. While opioid overdose driven demand is a major factor, growing awareness via NGO campaigns about opioid addiction and availability of overdose reversal drugs is anticipated to further bolster the U. Public health campaigns aim to reduce the stigma around opioid use disorders and naloxone, encouraging more people to keep it available. Threats: Growing availability and social acceptance of naloxone may weaken deterrence for risky opioid behaviors in some users. Regional analysis indicates the highest number of overdose deaths occurred in Northeastern states, making it currently the dominant market for naloxone products.
U.S. Opioids Market Is Estimated To Witness High Growth Owing To Increasing Prevalence Of Chronic Pain
Ashish Thapa 2023-09-12
img
The advantages of opioids include their ability to alleviate pain and improve the quality of life for patients with chronic pain conditions. The need for these products is driven by the increasing prevalence of chronic pain across the United States. The market is driven by increasing cases of chronic pain, the aging population, and the growing prevalence of conditions requiring palliative care. Furthermore, the rising awareness about pain management and the introduction of advanced technologies are also contributing to market growth. Regionally, the United States dominates the opioids market due to its well-established healthcare infrastructure, high healthcare expenditure, and the prevalence of chronic pain conditions.
What are the Current Trends and Key Players in the Dermal Filler Market?
Kanika Gupte 2022-09-19
img
com/request-sample/7654Dermal Filler Market business research report assesses the current as well as upcoming performance of the market, and also brand-new trends in the market. It provides product overview and highlights of product and application segments of the Dermal Filler Market including price, revenue, sales, sales growth rate, and market share by product. The Dermal Filler Market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics. Considering these factors, COVID-19 is expected to have a significant impact on the dermal filler market. The dermal filler market is not limited to facial skin procedures, but also includes treatment, which aesthetically changes the body.
U.S. Home Healthcare Market Growing Demand for in-Home Healthcare Services
Rajkumar cmi 2024-01-11
img
These services range from skilled nursing care and intravenous therapy to physiotherapy and assistance with daily living activities. The growing geriatric population prone to chronic diseases and disabilities has increased demand for such in-home services. Its widespread acceptance is set to drive further growth in the home healthcare market. Among these, the services segment dominates the market as people are increasingly preferring home health care for convenience and cost-effectiveness. Specifically, skilled nursing services is the largest sub-segment since it provides specialized care to patients through licensed nurses and therapists.
Evolving Perspectives: Ethanol's Role in the U.S. Fuel Sector
Vedant B 2024-03-26
img
S ethanol market has witnessed significant growth over the past few years due to the increasing demand for sustainable transportation fuels. The Renewable Fuel Standard program mandates blending of minimum volumes of renewable fuels like ethanol in gasoline every year. Infrastructure constraints also exist for sales and distribution of higher ethanol blends like E15 that require modifications at dispensing pumps. Over 50% of total ethanol production capacity is based in these states due to strategic location in the corn belt. Stringent low carbon fuel policies and presence of major fuel markets favor ethanol consumption growth in this region.
U.S. Naloxone Market is Estimated to Witness High Growth Owing to Increasing Cases of Opioid Overdose
Gauri Cmi 2023-09-18
img
The market is driven by the increasing cases of opioid overdose, which has become a major public health concern in the United States. Recognizing the urgency and severity of the opioid overdose crisis, many states in the U. These programs provide training to individuals on how to recognize the signs of opioid overdose and administer naloxone effectively. The government's initiatives to combat the opioid crisis and increase access to naloxone are expected to drive market growth. Additionally, the societal acceptance and promotion of naloxone as a critical intervention in opioid overdose emergencies contribute to market growth.
The global U.S. Imaging Services Market Growth Accelerated by Digital Adoption
Niranjan Mardakar 2024-02-01
img
The U. The U. 3 Mn in 2024 and is expected to exhibit a CAGR of 4. 9% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. This has increased accessibility of quality medical imaging services to large population base. This segment is dominating as diagnostic imaging enables early detection of diseases as well as aid in treatment decisions planning and monitoring. The U. 3 Mn in 2024 and is expected to exhibit a CAGR of 4.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight
Ankit Nigam 2020-10-12
img

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.

These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.

According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.

The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.

Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.